ÂÜÀòÂÒÂ×

Mr. Truex serves as Executive Chairman for LQT Therapeutics.

Before LQT Therapeutics, Mr. Truex recently served as the Executive Chairman, Director, and Chief Executive Officer of Anthera Pharmaceuticals.

Mr. Truex has been involved in over $5 billion in biotech financing and strategic transactions. His recent experience includes initial public offerings for Milestone (Board Member, 2019), Trius (Board Member, 2010), Anthera (CEO, 2010), Peninsula (CEO, 2004), and Versicor (Vice President, 2000). Mr. Truex was Founder, President, and CEO of Peninsula Pharmaceuticals which was acquired by Johnson & Johnson and Forest for more than $700 million.

Mr. Truex began his biotech career at Eli Lilly where his business development experience included the Lilly ICOS joint venture for the development of Cialis®. Mr. Truex is a member of the Board of Milestone (MIST), Cymabay (CBAY), Anthera (ANTH), and Gladius.

Mr. Truex obtained his MBA from Indiana University and a BA in Economics from the University of Waterloo.